Date: Tuesday 29th June 2021
Time: 14:00 - 15:00 BST
Speaker: Steve Bailey (Pfizer)
Who is this event intended for? Anyone interested in Carcinogenicity studies.
What is the benefit of attending? To learn about the hot topics and current thoughts on best practice.
This presentation will give some background regarding the ‘Carcinogenicity Statistics Discussion Group’, which is an industry group started by the ‘Nonclinical Biostatistics Leadership Forum’. The talk will review the history of the group, outline the current status, and give an overview of the types of topics discussed. Highlights from some past discussion topics will also be reviewed.
This event is free of charge, to both Members and Non Members of PSI.
To register for this event, please click here.
Please note: PSI have moved to a new membership platform called GlueUp. When registering for this event, you will be directed to this platform to complete your registration. If you are an existing member of PSI and are prompted to enter your login credentials, this will require the email address associated with your member record and the new password you created when activating your GlueUp account.
|
Speaker |
Biography |
|
Steven Bailey |
Steven Bailey has been supporting Preclinical Drug Safety for 37 years, initially at Wyeth, and more recently at Pfizer. He has provided statistical support and consulting to all areas of drug safety studies, but has particular expertise in carcinogenicity, developmental and reproductive toxicology, juvenile animal studies, and behavioral testing. Steve is a member of a number of Health and Environmental Science Institute (HESI) and International Consortium on Innovation and Quality in the Pharmaceutical Industry (IQ) cross-industry work teams. He has contributed to 2 books on analysis of preclinical animal studies, and has numerous articles to his credit. Steve received a BS in Mathematics and a MS in Statistics from Carnegie-Mellon University. In 2011, Steve was one of the first statisticians in the country to be certified as an 'Accredited Professional Statistician' (PStat) with the American Statistical Association. He is a member of the American Statistical Association and the Teratology Society. |
Date: Tuesday 29th June 2021
Time: 14:00 - 15:00 BST
Speaker: Steve Bailey (Pfizer)
Who is this event intended for? Anyone interested in Carcinogenicity studies.
What is the benefit of attending? To learn about the hot topics and current thoughts on best practice.
This presentation will give some background regarding the ‘Carcinogenicity Statistics Discussion Group’, which is an industry group started by the ‘Nonclinical Biostatistics Leadership Forum’. The talk will review the history of the group, outline the current status, and give an overview of the types of topics discussed. Highlights from some past discussion topics will also be reviewed.
This event is free of charge, to both Members and Non Members of PSI.
To register for this event, please click here.
Please note: PSI have moved to a new membership platform called GlueUp. When registering for this event, you will be directed to this platform to complete your registration. If you are an existing member of PSI and are prompted to enter your login credentials, this will require the email address associated with your member record and the new password you created when activating your GlueUp account.
|
Speaker |
Biography |
|
Steven Bailey |
Steven Bailey has been supporting Preclinical Drug Safety for 37 years, initially at Wyeth, and more recently at Pfizer. He has provided statistical support and consulting to all areas of drug safety studies, but has particular expertise in carcinogenicity, developmental and reproductive toxicology, juvenile animal studies, and behavioral testing. Steve is a member of a number of Health and Environmental Science Institute (HESI) and International Consortium on Innovation and Quality in the Pharmaceutical Industry (IQ) cross-industry work teams. He has contributed to 2 books on analysis of preclinical animal studies, and has numerous articles to his credit. Steve received a BS in Mathematics and a MS in Statistics from Carnegie-Mellon University. In 2011, Steve was one of the first statisticians in the country to be certified as an 'Accredited Professional Statistician' (PStat) with the American Statistical Association. He is a member of the American Statistical Association and the Teratology Society. |
Date: Tuesday 29th June 2021
Time: 14:00 - 15:00 BST
Speaker: Steve Bailey (Pfizer)
Who is this event intended for? Anyone interested in Carcinogenicity studies.
What is the benefit of attending? To learn about the hot topics and current thoughts on best practice.
This presentation will give some background regarding the ‘Carcinogenicity Statistics Discussion Group’, which is an industry group started by the ‘Nonclinical Biostatistics Leadership Forum’. The talk will review the history of the group, outline the current status, and give an overview of the types of topics discussed. Highlights from some past discussion topics will also be reviewed.
This event is free of charge, to both Members and Non Members of PSI.
To register for this event, please click here.
Please note: PSI have moved to a new membership platform called GlueUp. When registering for this event, you will be directed to this platform to complete your registration. If you are an existing member of PSI and are prompted to enter your login credentials, this will require the email address associated with your member record and the new password you created when activating your GlueUp account.
|
Speaker |
Biography |
|
Steven Bailey |
Steven Bailey has been supporting Preclinical Drug Safety for 37 years, initially at Wyeth, and more recently at Pfizer. He has provided statistical support and consulting to all areas of drug safety studies, but has particular expertise in carcinogenicity, developmental and reproductive toxicology, juvenile animal studies, and behavioral testing. Steve is a member of a number of Health and Environmental Science Institute (HESI) and International Consortium on Innovation and Quality in the Pharmaceutical Industry (IQ) cross-industry work teams. He has contributed to 2 books on analysis of preclinical animal studies, and has numerous articles to his credit. Steve received a BS in Mathematics and a MS in Statistics from Carnegie-Mellon University. In 2011, Steve was one of the first statisticians in the country to be certified as an 'Accredited Professional Statistician' (PStat) with the American Statistical Association. He is a member of the American Statistical Association and the Teratology Society. |
Date: Tuesday 29th June 2021
Time: 14:00 - 15:00 BST
Speaker: Steve Bailey (Pfizer)
Who is this event intended for? Anyone interested in Carcinogenicity studies.
What is the benefit of attending? To learn about the hot topics and current thoughts on best practice.
This presentation will give some background regarding the ‘Carcinogenicity Statistics Discussion Group’, which is an industry group started by the ‘Nonclinical Biostatistics Leadership Forum’. The talk will review the history of the group, outline the current status, and give an overview of the types of topics discussed. Highlights from some past discussion topics will also be reviewed.
This event is free of charge, to both Members and Non Members of PSI.
To register for this event, please click here.
Please note: PSI have moved to a new membership platform called GlueUp. When registering for this event, you will be directed to this platform to complete your registration. If you are an existing member of PSI and are prompted to enter your login credentials, this will require the email address associated with your member record and the new password you created when activating your GlueUp account.
|
Speaker |
Biography |
|
Steven Bailey |
Steven Bailey has been supporting Preclinical Drug Safety for 37 years, initially at Wyeth, and more recently at Pfizer. He has provided statistical support and consulting to all areas of drug safety studies, but has particular expertise in carcinogenicity, developmental and reproductive toxicology, juvenile animal studies, and behavioral testing. Steve is a member of a number of Health and Environmental Science Institute (HESI) and International Consortium on Innovation and Quality in the Pharmaceutical Industry (IQ) cross-industry work teams. He has contributed to 2 books on analysis of preclinical animal studies, and has numerous articles to his credit. Steve received a BS in Mathematics and a MS in Statistics from Carnegie-Mellon University. In 2011, Steve was one of the first statisticians in the country to be certified as an 'Accredited Professional Statistician' (PStat) with the American Statistical Association. He is a member of the American Statistical Association and the Teratology Society. |
Date: Tuesday 29th June 2021
Time: 14:00 - 15:00 BST
Speaker: Steve Bailey (Pfizer)
Who is this event intended for? Anyone interested in Carcinogenicity studies.
What is the benefit of attending? To learn about the hot topics and current thoughts on best practice.
This presentation will give some background regarding the ‘Carcinogenicity Statistics Discussion Group’, which is an industry group started by the ‘Nonclinical Biostatistics Leadership Forum’. The talk will review the history of the group, outline the current status, and give an overview of the types of topics discussed. Highlights from some past discussion topics will also be reviewed.
This event is free of charge, to both Members and Non Members of PSI.
To register for this event, please click here.
Please note: PSI have moved to a new membership platform called GlueUp. When registering for this event, you will be directed to this platform to complete your registration. If you are an existing member of PSI and are prompted to enter your login credentials, this will require the email address associated with your member record and the new password you created when activating your GlueUp account.
|
Speaker |
Biography |
|
Steven Bailey |
Steven Bailey has been supporting Preclinical Drug Safety for 37 years, initially at Wyeth, and more recently at Pfizer. He has provided statistical support and consulting to all areas of drug safety studies, but has particular expertise in carcinogenicity, developmental and reproductive toxicology, juvenile animal studies, and behavioral testing. Steve is a member of a number of Health and Environmental Science Institute (HESI) and International Consortium on Innovation and Quality in the Pharmaceutical Industry (IQ) cross-industry work teams. He has contributed to 2 books on analysis of preclinical animal studies, and has numerous articles to his credit. Steve received a BS in Mathematics and a MS in Statistics from Carnegie-Mellon University. In 2011, Steve was one of the first statisticians in the country to be certified as an 'Accredited Professional Statistician' (PStat) with the American Statistical Association. He is a member of the American Statistical Association and the Teratology Society. |
Date: Tuesday 29th June 2021
Time: 14:00 - 15:00 BST
Speaker: Steve Bailey (Pfizer)
Who is this event intended for? Anyone interested in Carcinogenicity studies.
What is the benefit of attending? To learn about the hot topics and current thoughts on best practice.
This presentation will give some background regarding the ‘Carcinogenicity Statistics Discussion Group’, which is an industry group started by the ‘Nonclinical Biostatistics Leadership Forum’. The talk will review the history of the group, outline the current status, and give an overview of the types of topics discussed. Highlights from some past discussion topics will also be reviewed.
This event is free of charge, to both Members and Non Members of PSI.
To register for this event, please click here.
Please note: PSI have moved to a new membership platform called GlueUp. When registering for this event, you will be directed to this platform to complete your registration. If you are an existing member of PSI and are prompted to enter your login credentials, this will require the email address associated with your member record and the new password you created when activating your GlueUp account.
|
Speaker |
Biography |
|
Steven Bailey |
Steven Bailey has been supporting Preclinical Drug Safety for 37 years, initially at Wyeth, and more recently at Pfizer. He has provided statistical support and consulting to all areas of drug safety studies, but has particular expertise in carcinogenicity, developmental and reproductive toxicology, juvenile animal studies, and behavioral testing. Steve is a member of a number of Health and Environmental Science Institute (HESI) and International Consortium on Innovation and Quality in the Pharmaceutical Industry (IQ) cross-industry work teams. He has contributed to 2 books on analysis of preclinical animal studies, and has numerous articles to his credit. Steve received a BS in Mathematics and a MS in Statistics from Carnegie-Mellon University. In 2011, Steve was one of the first statisticians in the country to be certified as an 'Accredited Professional Statistician' (PStat) with the American Statistical Association. He is a member of the American Statistical Association and the Teratology Society. |
